Airway Inflammation in Children with Primary Ciliary Dyskinesia

Scott D Sagel1, Oren Kupfer1, Brandie D Wagner2

  • 1Department of Pediatrics, Children's Hospital Colorado, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

Insights

In children with primary ciliary dyskinesia (PCD), higher sputum inflammation markers correlate with worse lung function and structural damage. These inflammatory measurements may serve as useful biomarkers for disease progression in pediatric PCD patients.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Immunology

Background:

  • Airway inflammation's role in primary ciliary dyskinesia (PCD) pathogenesis in children is not well understood.
  • Investigating inflammation markers in pediatric PCD is crucial for understanding disease progression and identifying therapeutic targets.

Purpose of the Study:

  • To examine the associations between sputum inflammation markers, age, lung function, bronchiectasis, airway infection, and ultrastructural defects in children with PCD.
  • To determine if sputum inflammatory measurements can serve as biomarkers in pediatric PCD.

Main Methods:

  • Collected spontaneously expectorated sputum from 77 clinically stable children and adolescents (ages 6+) with PCD in a multicenter observational study.
  • Correlated sputum protease and inflammatory cytokine concentrations with age, lung function (FEV1% predicted), and chest CT measures of structural lung disease.
  • Compared inflammatory marker concentrations between different ultrastructural defect categories and between those with and without detectable bacterial infection.

Main Results:

  • Elevated sputum neutrophil elastase, IL-1β, IL-8, and TNF-α concentrations positively correlated with age, bronchiectasis extent, and overall structural lung disease on CT.
  • These inflammatory markers negatively correlated with lung function (FEV1% predicted).
  • Higher concentrations of sputum neutrophil elastase, IL-1β, and TNF-α were found in children with detectable bacterial pathogens.

Conclusions:

  • In pediatric PCD, increased sputum proteases and cytokines are linked to diminished lung function and structural lung damage.
  • Sputum inflammatory measurements show potential as valuable biomarkers for assessing disease status and progression in children with PCD.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.0K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
376
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
215
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
549